Frontlight ResearchEarly access
Lung cancer trials in Israel
68 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Where
- Beer Ya'akov, Haifa, Jerusalem, Kefar Sava, Petah Tikva, Ramat Gan, Tel Aviv
- Age
- 18 years and over
- People
- 694 worldwide
- Run by
- AbbVie
See details and how to joinNCT05005403 - No phaseTaking peopleEx Vivo Drug Response Profiling and Outcome Prediction in Lung Adenocarcinoma
- Where
- Ramat Gan
- Age
- 18 years and over
- People
- 400
- Run by
- Sheba Medical Center
See details and how to joinNCT07636252 - No phaseTaking peopleAlpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Lung Cancer
- Where
- Jerusalem
- Age
- 18 years and over
- People
- 10
- Run by
- Alpha Tau Medical LTD.
See details and how to joinNCT05632913 - Phase 1Taking peopleStudy With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- Where
- Jerusalem, Petah Tikva, Ramat Gan
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- Calico Life Sciences LLC
See details and how to joinNCT04777994 · EU 2023-507568-38-00 - Phase 1Taking peoplePhase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
- Where
- Kfar Saba, Tel HaShomer
- Age
- 18 years and over
- People
- 304 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT04686305 · EU 2023-504949-31-00 - No phaseTaking peopleAssociation Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
- Where
- Tel Aviv
- Age
- 18 years and over
- People
- 300
- Run by
- Daniel Keizman
See details and how to joinNCT07485114 - Phase 1/2Taking peopleAutologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
- Where
- Jerusalem
- Age
- 18 years and over
- People
- 50
- Run by
- Hadassah Medical Organization
See details and how to joinNCT00722228 - Phase 1/2Taking peopleAnti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
- Where
- Jerusalem
- Age
- 18 years to 70 years
- People
- 3
- Run by
- Hadassah Medical Organization
See details and how to joinNCT05296564 - No phaseTaking peopleReal World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Resection
- Where
- Ramat Gan
- Age
- 18 years and over
- People
- 60
- Run by
- Sheba Medical Center
See details and how to joinNCT07131163 - Phase 2Not yet taking people in IsraelTracking T-Cell Responses to Evaluate Pembrolizumab Effectiveness in Advanced Non-Small Cell Lung Cancer
- Where
- Petah Tikva
- Age
- 18 years and over
- People
- 30
- Run by
- Rabin Medical Center
See details and how to joinNCT06951399 - No phaseTaking peopleNovel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer
- Where
- Ramat Gan
- Age
- 18 years and over
- People
- 300
- Run by
- JaxBio Ltd
See details and how to joinNCT06963307 - No phaseEnrolling by invitationALK Digital Pathology Outcome Predition, Multi Institutional, Restrospective Study
- Where
- Ramat Gan
- Age
- 18 years and over
- People
- 200
- Run by
- Sheba Medical Center
See details and how to joinNCT06846736 - Phase 2Taking peopleFirst Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+Trodelvy
- Where
- Jerusalem
- Age
- 18 years to 99 years
- People
- 21
- Run by
- Nir Peled
See details and how to joinNCT06667167 - No phaseTaking peopleFirst in Human Study for the Assessment of Safety and Initial Performance of the EAS1 System
- Where
- Kfar Saba
- Age
- 18 years to 80 years
- People
- 15 worldwide
- Run by
- Snipe Medical
See details and how to joinNCT06423690 - Phase 2Taking peopleFecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer
- Where
- Beersheba, Petah Tikva
- Age
- 18 years and over
- People
- 80
- Run by
- Soroka University Medical Center
See details and how to joinNCT05502913 - No phaseNot yet taking people in IsraelA Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC
- Where
- Jerusalem
- Age
- 18 years and over
- People
- 50
- Run by
- Nir Peled
See details and how to joinNCT05698264 - No phaseTaking peopleI3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
- Where
- Jerusalem
- Age
- 18 years and over
- People
- 2,200 worldwide
- Run by
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT05537922 - No phaseTaking peopleA Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases
- Where
- Jerusalem
- Age
- 18 years to 120 years
- People
- 162
- Run by
- Hadassah Medical Organization
See details and how to joinNCT05033691